Testing for cancer may soon be as simple as a pinprick. Researchers in the United Kingdom say they are developing a universal blood test to detect cancer. So far, the team from the University of Bradford has tested their lymphocyte genome sensitivity test on patients with melanoma, lung cancer and colon cancer.esting for cancer may soon be as simple as a pinprick. Researchers in the United Kingdom say they are developing a universal blood test to detect cancer. So far, the team from the University of Bradford has tested their lymphocyte genome sensitivity test on patients with melanoma, lung cancer and colon cancer.
Aicardi syndrome is a rare neurologic disorder first described by the French neurologist, Dr. Jean Aicardi, in 1965. It occurs almost exclusively in females (46,XX), however, it can also occur in males with Klinfelter Syndrome (47,XXY). A handful of reports in the literature exist of Aicardi syndrome in a normal male. Some of these reports have been disputed, and it is possible that these cases are caused by mosaic mutations of the Aicardi syndrome gene(s).
The four types of oculocutaneous albinism each result from mutations in a single gene: TYR, OCA2, TYRP1, or SLC45A2. Changes in the TYR gene cause type 1; mutations in the OCA2 gene are responsible for type 2; TYRP1 mutations cause type 3; and changes in the SLC45A2 gene result in type 4.he four types of oculocutaneous albinism each result from mutations in a single gene: TYR, OCA2, TYRP1, or SLC45A2. Changes in the TYR gene cause type 1; mutations in the OCA2 gene are responsible for type 2; TYRP1 mutations cause type 3; and changes in the SLC45A2 gene result in type 4.